SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy

Identifying patients at risk of poor response to neoadjuvant chemoradiotherapy (nCRT) is an emerging clinical need in locally advanced rectal cancer (LARC). SMAD3 is a key player in the chemoradio-resistance phenotype and its expression is both constitutive and locally induced. The aim was to invest...

Descripción completa

Detalles Bibliográficos
Autores principales: De Mattia, Elena, Canzonieri, Vincenzo, Polesel, Jerry, Mezzalira, Silvia, Dalle Fratte, Chiara, Dreussi, Eva, Roncato, Rossana, Bignucolo, Alessia, Innocente, Roberto, Belluco, Claudio, Pucciarelli, Salvatore, De Paoli, Antonino, Palazzari, Elisa, Toffoli, Giuseppe, Cecchin, Erika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740633/
https://www.ncbi.nlm.nih.gov/pubmed/35002714
http://dx.doi.org/10.3389/fphar.2021.778781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740633/
https://www.ncbi.nlm.nih.gov/pubmed/35002714
http://dx.doi.org/10.3389/fphar.2021.778781

Ejemplares similares